Assessing Helicobacter Pylori Infection Rates in Families in Jiangsu

The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu Based on Non-invasive PCR in Stool

Observational Nanjing First Hospital, Nanjing Medical University · NCT05654857

This study looks at how common Helicobacter pylori infections are in families in Jiangsu, China, and checks if the bacteria are resistant to antibiotics.

Quick facts

Study typeObservational
Enrollment4000 (estimated)
Ages6 Years and up
SexAll
SponsorNanjing First Hospital, Nanjing Medical University Academic / other
Locations16 sites (Changzhou, Jiangsu and 15 other locations)
Trial IDNCT05654857 on ClinicalTrials.gov

What this trial studies

This observational study aims to evaluate the prevalence of Helicobacter pylori infection and the rates of antimicrobial resistance within family units in Jiangsu, China. The research involves collecting stool samples from community members, which will be analyzed using real-time PCR to detect the presence of the infection and any drug-resistant gene mutations. The study focuses on understanding the infection dynamics within families to inform public health strategies. Participation requires informed consent and adherence to specific eligibility criteria.

Who should consider this trial

Good fit: Ideal candidates for this study are community members from Jiangsu who can provide stool samples and meet the study's inclusion criteria.

Not a fit: Patients who have recently used antibiotics or other medications affecting Helicobacter pylori, or those unable to provide adequate stool samples, may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the prevalence of Helicobacter pylori infections and resistance patterns, potentially guiding more effective treatment strategies.

How similar studies have performed: While similar studies have been conducted, this specific focus on family units and antimicrobial resistance in Jiangsu presents a novel approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. community population
2. Fecal samples can be obtained, and the sample volume meets the requirements of the collection tube instructions
3. Only one person per family can be selected
4. Voluntarily participated in this study and signed an informed consent form

Exclusion Criteria:

1. The collector does not cooperate or has poor compliance;
2. Adequate and qualified fecal samples could not be obtained;
3. Stool samples were collected during diarrhea or constipation;
4. Antibiotics, bismuth preparations, proton pump inhibitors and other Hp sensitive drugs have been used within one month.

Where this trial is running

Changzhou, Jiangsu and 15 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Helicobacter Pylori InfectionResistance MutationFecal Drug Resistance Gene Detection
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.